Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr. Sharpless is well aware of the DCVax Platform. He was scheduled to visit as the director of the National Cancer Institute and participate in a seminar at UCLA on April 17th with Dr. Linda Liau, but had to cancel since it conflicted with his new position at the FDA. The new acting commissioner of the FDA since Scott Gottlieb stepped down.
Yes, correct. However, very soon NWBO will be trading up on 10,000,000 shrs. + in the first hour and then the MM's trying to control the lower price will find themselves lost and impotent. There'll be no turning back at that point.
That's his MO. I purchased his books and was a follower of him and MM, but finally got wiser when I saw the pattern of his ways. JMHO
I agree, the sooner the better.
* Better economically for NWBO operations
* Better for the FDA to finally announce that a serious response to
the to the deadly disease of GBM is at hand and under review.
* Better for LP and LL for delivering abstract for SNO 2019 conference
* Finally, better for all those patients suffering from GBM and
eventually with off label use anyone suffering with inoperable solid
tumor cancers.
Remember, September 1 is the cutoff date for any late SNO conference abstracts.
I guess its the price to pay in order to play.
Flipper,
So what do you think lights the fuse???
Hear Hear
Any guesses on where we end up on volume today?
I guess one of the next questions will be how quick and how contagious will this buying frenzy erupt and when can we expect a PR?
Well, someone did say , "Don't miss the boat".
:)
I admit it's lame, but sometimes those with any inside info are very very close to the source and without much resource.
So it looks like in the last fifteen minutes of trading yesterday, the price went from $.1925 to $.2000. About 30,000 shrs traded during that time. Then also yesterday, JC said he wouldn't buy more NVCR. He would take some off the table. Not sure if there is any correlation with the two, but I do find the timing of it interesting. Just have to wait and see if there is any more to it. JMHO
Great post Sukus. I agree with your statement on Dr. Sharpless as he stated that no cancer ticks him off more than GBM and he would love to see some response that would combat this cancer.
Can't be long now till topline results. I sure wouldn't want to be long on NVCR now. Thanks again Sukus.
Hans,
Yes, Correct.
Getting more and more exciting as each day passes.
:)
They don't have to declare, and why would they? Why give anyone a heads up on your reporting data?
For the 2019 SNO Conference presentation.
Only twelve days remain till deadline for a final Late-Breaking abstract (with updated data) for this years SNO conference.
Tilt,
do you think the LP will keep the trial going just to force BP's
hand? or keep to her original plan of getting the four SAP's approved, top line and then going for approval. Once approved in any of the four regions, then, immediately moving DCVax-L into production? Consequently again forcing BP's hands for negotiation and buyout but, at a much steeper value?
TIA.
Hans
I didn't even think of that, excellent, excellent point... I wouldn't put it past him to scheme such a plan. Oh, and by the way it was the CEO who sold $11.3 million in stock shares just post ASCO.
Thanks,
Exactly,
I'm sure he knew post ASCO that just in case DCVax-L gets approved that like you already said and pointed out that Optune survival stats will quickly be compared to Top Line Results from DCVax-L. Hence, liquidate some holding stock. Right? JMHO
Why then??? Why right after ASCO 2019 ???
Why didn't he transact that sale prior to ASCO 2019???
What did he learn at ASCO?
Yea, I think that was their CCO P. Shah for just over $500,000 value. However more interesting than that was the sale of stock in three different transactions by their CEO Danziger just after the close of the 2019 ASCO for a value over $11.3 million. Now ask yourself why is that? Why did he do that? and why just after the ASCO conference. Kind of makes you go Hmmmm???
I find it interesting that on an average volume day for NVCR where only 757K shares traded hands where their three month average is only 764K and where the nasdaq ended down $7.32 or .09%, that NVCR ended up by $4.12 or 4.77%. Now, why is that? What is the purpose of MM's pushing this up??? Someone on this board(can't remember who) stated when NVCR started their upward move that they possibly have an agenda of pushing it up so to sell NVCR at a high. Sure looks more and more like that comment has some substance to it. But who would buy it and why?
I believe that as well. BP most definitely has NWBO on their radar and possibly a few may already have tentative offers dependent on top line approval. LP will be the most sought after CEO once top line is announced. Finally, watch how quickly DCVax-L gets approved by the FDA once a BP Bid is accepted by NWBO. IMHO
Most definitely. But I think the market will ultimately judge for itself and most assuredly value the DCVax Platform as the choice SOC for GBM and probably any solid cancer disease. IMHO
Agreed. Making the microwave helmut obselete can't come soon enough.
Tilt,
Do you think that is why we saw a little bit of a jump yesterday by what almost .028 early in the day? Maybe one or two associates got wind of some data or info?
TIA,
Hans
And, you can leave your microwave oven at home. IMHO
Totally Totally Agree. No selling till BO. LP is the Boss and we'll do just fine by her. No regrets.
I'm ready. Got my umbrella upside down. :)
Totally agree on news out anytime now. The volume is up, the fudsters are out of control and the size on the current bids are growing. YabaDabaDo.
Exactly !!!!
That is the only ammunition they have left. FUD, FUD and more FUD. Pathetic Losers.
Agreed, Agreed, Agreed. I also hope that the FDA makes the same request to NVCR as soon as NWBO releases their top line data.
WooHoo!!!! Happy Days, Happy Days
Hear Hear. Strongly Agree...
the ceo has already started cashing out. Just google NVCR CEO selling stock. As far as getting caught for their irresponsible actions, they'll have to live with that on their conscience all their remaining days here on earth.
GGB, agreed on the fact that the FDA approved Optune based on the information reported by Stupp and NVCR. And, he may be sipping Mai-Tai's in Hawaii as well. However if further scrutiny of that information does materialize as I expect it will then Stupp or someone from NVCR will have to substantiate their riduculous survival claims. In the long run the capital market will do all the talking as NWBO DCVax-L will become SOC and their Direct pipeline product will be given full attention for speed to market. :)
Unfortunately, you're going to have to wait till the top line results are announced. That's just the way it is. However, once that is done, then, you will see NVCR and Dr. Stupp begin to squirm hesitate as he searches for facts to substantiate his claims. Furthermore, I still want to know why the CEO sold $11.3 million in shares just after the close of ASCO. IMHO
Agreed, the fact that there are so many more survivors from the DCVax-L GBM trial speaks volumes for me. No way getting around that fact. :)
Thanks,
Hans
Submission for late breaking abstract for upcoming SNO Conference:
"Submit a final Late-Breaking abstract (with updated data) by September 1, 2019. If an updated abstract is not submitted by that date, the abstract will be automatically rejected."